Results 131 to 140 of about 1,927 (159)

Einmal täglich Raltegravir funktioniert [PDF]

MMW - Fortschritte der Medizin, 2016
openaire   +1 more source

Patterns of Adherence to Raltegravir-Based Regimens and the Risk of Virological Failure Among HIV-Infected Patients

, 2012
Guillaume Gras, Marie Paule Schneider, Matthias Cavassini, F. Lucht, Magalie Loilier, Renaud Verdon, Louis Bernard, Jean‐Jacques Parienti   +7 more
openalex   +1 more source

Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection

, 2012
Eduardo Gotuzzo, Martin Markowitz, Winai Ratanasuwan, Graham Smith, Guillermo Prada, Javier O Morales-Ramirez, Kim M. Strohmaier, Chengxing Lu, S. Bhanja, Bach‐Yen Nguyen, Hedy Teppler   +10 more
openalex   +1 more source

Immunologic Effectiveness of Maraviroc- and Raltegravir-Containing Regimens (R+M+) versus Raltegravir-Based Regimens That Do Not Include Maraviroc (R+M−)

, 2012
Tony Antoniou, Graham Smith, DeSheng Su, Janet Raboud, Derek Lee, Colin Kovacs, Jason Brunetta, David Fletcher, Fred Crouzat, Mona Loutfy   +9 more
openalex   +1 more source

Viral Dynamic Model of Antiretroviral Therapy Including the Integrase Inhibitor Raltegravir in Patients with HIV-1

, 2012
Dimitra Bon, Christoph Stephan, Oliver T. Keppler, Eva Herrmann   +3 more
openalex   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Raltegravir

Drugs, 2008
* Raltegravir, the first in a new class of orally administered HIV type-1 (HIV-1) integrase inhibitors, selectively inhibits the strand transfer activity of HIV-1 and its integration into human DNA, a key stage in retroviral propagation, thereby limiting viral replication and the infection of new cells.
Jamie D, Croxtall, Katherine A, Lyseng-Williamson, Caroline M, Perry   +2 more
openaire   +2 more sources

The Effect of Raltegravir on the Glucuronidation of Lamotrigine

The Journal of Clinical Pharmacology, 2009
The authors studied the effect of raltegravir on the pharmacokinetics of the antiepileptic agent lamotrigine. Twelve healthy volunteers (group A) received 400 mg raltegravir twice daily from days 1 to 5. On day 4, a single dose of 100 mg lamotrigine was administered.
Luin, M. van, Colbers, A., Verwey-van Wissen, C.P.W.G.M., Ewijk-Beneken Kolmer, E.W.J. van, Kolk, M. van der, Hoitsma, A.J., Silva, H.G. da, Burger, D.M.   +7 more
openaire   +4 more sources

Raltegravir-induced DRESS syndrome

Scandinavian Journal of Infectious Diseases, 2012
DRESS syndrome (drug reaction with eosinophilia and systemic symptoms) is a life-threatening adverse drug reaction. Raltegravir is an integrase inhibitor used in HIV-1 infection. We report on a patient who developed a DRESS syndrome under raltegravir treatment, which was identified as a probable case of DRESS on the basis of Kardaun and Naranjo scores.
Olivier Mir, Pierre Loulergue
openaire   +3 more sources

Raltegravir Potassium

Hospital Pharmacy, 2008
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to your Pharmacy & Therapeutics Committee. Subscribers also receive monthly 1-page summary monographs on the agents that are useful for agendas and pharmacy/
Dennis J. Cada, Danial E. Baker, Terri Levien   +2 more
openaire   +2 more sources

Effect of Raltegravir on the Pharmacokinetics of Methadone

The Journal of Clinical Pharmacology, 2010
A randomized, placebo‐controlled, 2‐period crossover study in subjects on methadone maintenance therapy was conducted to assess the effect of the HIV‐1 integrase inhibitor, raltegravir, on the pharmacokinetics of methadone. Twelve HIV‐negative male and female subjects stabilized on an oral methadone program were enrolled.
Julie Ann Mabalot Luk, Robert A. Riesenberg, Marian Iwamoto, Jeffery A. Chodakewitz, William D. Hanley, Larissa Wenning, Bo Jin, Matt S. Anderson, John A. Wagner   +8 more
openaire   +3 more sources